News

The social and psychological effects of vitiligo, particularly concerning gender disparities, have come to the forefront in recent literature.

Two recent studies delve into outcomes of pediatric populations with atopic conditions and an overview of patient outcomes utilizing a Mendelian randomization analysis.

On March 6, 2024, Valisure, an independent testing laboratory, found high levels of benzene when BPO products were incubated at 37°C, 50°C, and 70°C.

From our March cover feature: Vulnerable populations such as the prison population should have access to Mohs surgery to prevent the increased risk of morbidity and mortality from skin cancer.

The anticipated PDUFA date is November 4, 2024.

It has been 4 years since the COVID-19 pandemic began. In the time since, there has been plentiful research regarding its implications in dermatology.

The data suggests that the medication, which targets specific cellular pathways, promotes hair regrowth in AA with minimal adverse effects.

Keep up with the latest headlines in dermatology from the past week, including the AAD's vote to protect diversity, equity, and inclusion programs, a UK company's effort to democratize dermatologists’ services, and more.

ICYMI, this week we had news about AAD sessions and late-breaking research, the establishment of the very first annual National Dermatologist Day, benzene updates, and more.

This week’s collection of the latest dermatologic studies covers the relationship between vitamin D receptor expression and cutaneous melanoma outcomes, efficacy of intravenous immunoglobulin in adults with treatment-resistant eosinophilic fasciitis, high dose oral isotretinoin versus low dose for cutaneous and genital warts, and the loss of integrity in the dermal-epidermal junction and hemidesmosomes during skin aging.

The data was presented in a scientific session at the American Academy of Dermatology annual meeting.

With 30 years of clinical dermatology research under her belt, Draelos responds to recent benzene and BPO news in this Q&A.

A panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.

Tween skin care has become a rising trend across social media platforms such as TikTok, and dermatology clinicians are becoming increasingly concerned about misinformation.

Following Valisure’s Citizen’s Petition to the US Food and Drug Administration, we are recapping recent years of regulatory action regarding benzene and carbomers.

A news release from the American Academy of Dermatology addressed skin-related issues that disproportionately affect LGBTQ+ individuals.

Acelyrin announced the positive results, of which the primary endpoint was met with high statistical significance, earlier this week.

A panel of experts discusses unique needs of patients with skin of color, look at long-term safety and efficacy of emerging oral treatments, and delve into combining topicals with systemic therapies.

Patients with psoriatic disease face an increased risk of cardiovascular disease. Clinicians should consider this when determining management and treatment modalities for patients with psoriasis.

We've compiled all our coverage from the biggest dermatology meeting of the year to give you a thorough recap of everything you need to know or catch up on.

Allergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Ahead of the next 3 months of the year, Dermatology Times wants to know what conferences and meetings you plan to attend between April and June. Share your thoughts with us by March 27.

A panel of experts discuss navigating regimen complexity, patient-friendly adherence strategies, addressing steroid phobia and attitudes, and dive into current treatment guidelines.

The newly-established observation is a recognition of the commitment of dermatologists to serving the public and aims to bring awareness to the role of dermatology visits, skin checks, and more.

Our March 2024 publication features stories that reflect the sense of growth and newness in the specialty.

Catch up on coverage from the fifth and final day of the 2024 American Academy of Dermatology Annual Meeting.

Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.

Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.

In between sessions, Lal shared his favorite pearls from AAD, a recent challenging pediatric case in his practice, the significance of LinkedIn, and more.

Arianne Shadi Kourosh, MD, MPH, FAAD, shared pearls on environmental factors that can impact skin aging and pigmentation including visible light, IR radiation, location, and pollution.